Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 29;12(7):dmm039347.
doi: 10.1242/dmm.039347.

Disease modelling in human organoids

Madeline A Lancaster  1 , Meritxell Huch  2   3   4
Affiliations
Review

Disease modelling in human organoids

Madeline A Lancaster et al. Dis Model Mech. .

Abstract

The past decade has seen an explosion in the field of in vitro disease modelling, in particular the development of organoids. These self-organizing tissues derived from stem cells provide a unique system to examine mechanisms ranging from organ development to homeostasis and disease. Because organoids develop according to intrinsic developmental programmes, the resultant tissue morphology recapitulates organ architecture with remarkable fidelity. Furthermore, the fact that these tissues can be derived from human progenitors allows for the study of uniquely human processes and disorders. This article and accompanying poster highlight the currently available methods, particularly those aimed at modelling human biology, and provide an overview of their capabilities and limitations. We also speculate on possible future technological advances that have the potential for great strides in both disease modelling and future regenerative strategies.

Keywords: Embryonic development; In vitro; Regenerative medicine; Stem cells.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adey A., Burton J. N., Kitzman J. O., Hiatt J. B., Lewis A. P., Martin B. K., Qiu R., Lee C. and Shendure J. (2013). The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 500, 207-211. 10.1038/nature12064 - DOI - PMC - PubMed
    1. Adli M. (2018). The CRISPR tool kit for genome editing and beyond. Nat. Commun. 9, 1911 10.1038/s41467-018-04252-2 - DOI - PMC - PubMed
    1. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H. and Boyd M. R. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601. - PubMed
    1. Antonica F., Kasprzyk D. F., Opitz R., Iacovino M., Liao X.-H., Dumitrescu A. M., Refetoff S., Peremans K., Manto M., Kyba M. et al. (2012). Generation of functional thyroid from embryonic stem cells. Nature 491, 66-71. 10.1038/nature11525 - DOI - PMC - PubMed
    1. Artegiani B., van Voorthuijsen L., Lindeboom R. G. H., Seinstra D., Heo I., Tapia P., López-Iglesias C., Postrach D., Dayton T., Oka R. et al. (2019). Probing the tumor suppressor function of BAP1 in Crispr-engineered human liver organoids. Cell Stem Cell 24, 927-943.e6. 10.1016/j.stem.2019.04.017 - DOI - PubMed

Publication types